Speakers
Ad Antonisse, Director Market Access & External Affairs, AstraZeneca BV
Fausto Artico, Global R&D Tech Head of Innovation and Data Science, GSK
Marnix Artz, Head of Patient Access, Pricing & Public Affairs, Netherlands, Merck Group
Dorothee Bartels, Global Head RWE, UCB
Alexander Bastian, VP Value & Market Access, A.M. Pharma
Tomer Ben Zaken, Regional Business Operation Lead, Takeda
Mr Jesper Bjerggren, European Market Access Lead Respiratory/Digital Health, Teva Pharmaceuticals
Axel Boehnke, Director Market Access EU North, PTC Therapeutics
Amanda Bok, Chief Executive Officer, European Haemophilia Consortium
Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA & APAC, PTC Therapeutics
Vidya Breeveld, Founder, Transmineo
Irena Brookes-Smith, Senior Director RWE Strategy & Capabilities, AstraZeneca
Sandro Cesaro, Head, Market Access and Innovative Value Strategies, Oncology Europe, AstraZeneca
Mata Charokopou, Head of Payer value Strategy, UCB
Ms Helene Chevrou-Severac, HEOR RWE Centre of Excellence Head, International & Japan, Alexion
José Luis Sánchez Chorro, Market Access Director Spain and Portugal, Jazz Pharmaceuticals
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Frederic Ernst, Head of Market Access for Europe, Santen
Gina Ewy, Market Access, Hansa Biopharma
Graham Foxon, Managing Director, remap consulting
Philippe Ghyssels, VP Corporate and Global Public Affairs, Ipsen
Christoph Glaetzer, Chief Global Value and Access Officer, Janssen
Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy
Dr Alicia Granados, Global Medical RD Scientific Advocacy Head, Sanofi
Laura Guarga, Consultant of Pharmacoeconomic Department, CatSalut
Tanja Heidbrede, Head RWE Central EU, UCB
Pall Jonsson, Programme director for Data, Nice
Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, roche
Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator applications
Jolanda Koenders, Head of Patient Value and Access, Takeda Nederland
Augusta Elizabeth Koroma, Chief Executive Officer, Sickle cell Intervention U.K
Giovanny Leon, Pricing & Access Regional Director - LatAm & Canada, Novartis AG
Herve Lilliu, Chief Executive Officer, Inbeeo
Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada
James Maddocks, International Policy Advisor, NHS Confederation
Bart Malfait, Director Government Affairs & Market Access (BeLux), Astra Zeneca
Marco Marchetti, Director of Health Technology Assessment Unit, National Agency for Regional Care Services, Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas
Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd
Mario Ouwens, Group Director Medical & Payer Evidence Statistics, AstraZeneca
Francis Pang, VP Global Market Access, Orchard Therapeutics
Michela Pantaleoni, Head of Market Access Rare Diseases Europe & Emerg, Chiesi Global Rare Disease
Julien Patris, Director Market Access & Policy – Europe / Canada / MEA (CEMEA), Alnylam
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Lara Pippo, Head Of Market Access, Italy, CSL Behring
Ana Plata, Head of Global Pricing Implementation BBU, AstraZeneca
Luis Prieto Rodriguez, Global Real-World Evidence Director, Novartis
Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche
Sybille Riou, Global Market Access Manager, Miltenyi Biomedicine
Sandrine Ruiz, Director Global Market Access and Pricing, Independent
Sophie Schmitz, Managing Partner, Partners4Access
Michael Schroter, Co-Head Sustainable Healthcare Equity, Hsbc
Ayman Semaan, Head of Market Access, Biologix
Navin Sewak, Global Market Access Director, ViiV Healthcare
Helen Stoop, Head of Tender Excellence & PDT Payer Value, Takeda
Jan Swiderski, Public Affairs & Advocacy Director, Ipsen
Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation
Giovanni Tafuri, Director International Market Access and Policy, Apellis Pharmaceuticals
Ilona Torontali, Global Head Pricing and Reimbursement, Roche
Sheela Upadhyaya, Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist, National Institute for Health and Care Excellence
Andreas Uttenweiler, Head Patient Value Access & Public Affairs, Takeda Pharma AG
Bart Van Den Daele, Head of External Affairs – Director Market Access - Belux, Gilead Sciences
Goedele Van Haasteren, Staff Member, Swiss Federal Office of Public Health
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, CZ
Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia
Natasa Zibelnik, Global Head of Value, Access and Pricing, Eusa Pharma
Zinajda Zolic-Karlsson, Senior Advisor HTA and Reimbursement, Norwegian Medicines Agency
Get Involved
To Sponsor Or Exhibit
David Boore
david.boore@terrapinn.com
+44 20 8164 3052
To Speak
Francesca Wiggins
francesca.wiggins@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events